Insights

Innovative Therapeutics Cavion specializes in developing first-in-class therapies targeting neurological and rare genetic diseases through modulation of T-type calcium channels, presenting opportunities to collaborate on cutting-edge neurological treatment solutions.

Recent Acquisition The company's acquisition by Jazz Pharmaceuticals for $52.5 million highlights its potential and recent validation, making it a strategic partner for organizations looking to invest in or expand within innovative biotech markets.

Pipeline Progress Cavion's recent Phase 2 clinical trial results for essential tremor demonstrate a progressing pipeline, indicating potential timelines for market entry and opportunities for early-stage collaboration or product integration.

Funding & Growth With $26 million in venture financing and a revenue range of $1M to $10M, Cavion is positioned for further growth and R&D expansion, inviting partnership opportunities for advanced therapeutic development or distribution channels.

Focus on Neurological Disorders Cavion's core focus on neurological and cancer applications provides avenues to offer specialized services, technologies, or joint ventures aimed at accelerating drug development and clinical trials in these high-demand areas.

Cavion, Inc. Tech Stack

Cavion, Inc. uses 8 technology products and services including Hoefler&Co, Slick, jQuery, and more. Explore Cavion, Inc.'s tech stack below.

  • Hoefler&Co
    Font Scripts
  • Slick
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • X-XSS-Protection
    Security
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Cavion, Inc.'s Email Address Formats

Cavion, Inc. uses at least 1 format(s):
Cavion, Inc. Email FormatsExamplePercentage
Last@cavionpharma.comDoe@cavionpharma.com
40%
First@cavionpharma.comJohn@cavionpharma.com
10%
Last@cavionpharma.comDoe@cavionpharma.com
40%
First@cavionpharma.comJohn@cavionpharma.com
10%

Frequently Asked Questions

Where is Cavion, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Cavion, Inc.'s main headquarters is located at 600 East Water Street Suite E Charlottesville, Virginia 22902 US. The company has employees across 2 continents, including North AmericaSouth America.

What is Cavion, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Cavion, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cavion, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Cavion, Inc.'s official website is cavionpharma.com and has social profiles on LinkedIn.

What is Cavion, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Cavion, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cavion, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2019, Cavion, Inc. has approximately 17 employees across 2 continents, including North AmericaSouth America. Key team members include Senior Analyst: K. P.Analyst: V. L.. Explore Cavion, Inc.'s employee directory with LeadIQ.

What industry does Cavion, Inc. belong to?

Minus sign iconPlus sign icon
Cavion, Inc. operates in the Biotechnology Research industry.

What technology does Cavion, Inc. use?

Minus sign iconPlus sign icon
Cavion, Inc.'s tech stack includes Hoefler&CoSlickjQueryX-XSS-ProtectionGoogle AnalyticsAdobe FontsApache HTTP ServerApache.

What is Cavion, Inc.'s email format?

Minus sign iconPlus sign icon
Cavion, Inc.'s email format typically follows the pattern of Last@cavionpharma.com. Find more Cavion, Inc. email formats with LeadIQ.

How much funding has Cavion, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2019, Cavion, Inc. has raised $26M in funding. The last funding round occurred on Aug 15, 2017 for $26M.

When was Cavion, Inc. founded?

Minus sign iconPlus sign icon
Cavion, Inc. was founded in 2006.

Cavion, Inc.

Biotechnology ResearchVirginia, United States11-50 Employees

Cavion, Inc. is a clinical-stage company developing first-in-class therapies to restore the brain’s natural rhythms by modulating overactive T-type calcium channels for a range of neurological and rare genetic diseases. Cavion’s mission is to combine our deep understanding of T-type calcium channel (Cav3) biology with superior chemistry and clinical research expertise to provide therapeutics that will improve people’s lives. As we work to bring these therapies to market, Cavion will innovatively improve all aspects of trial conduct and patient engagement.

Section iconCompany Overview

Headquarters
600 East Water Street Suite E Charlottesville, Virginia 22902 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $26M

    Cavion, Inc. has raised a total of $26M of funding over 1 rounds. Their latest funding round was raised on Aug 15, 2017 in the amount of $26Mas a venture financing.

  • $1M$10M

    Cavion, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $26M

    Cavion, Inc. has raised a total of $26M of funding over 1 rounds. Their latest funding round was raised on Aug 15, 2017 in the amount of $26Mas a venture financing.

  • $1M$10M

    Cavion, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.